Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lipitor, Lovastatin Are “Best Buy” Statins, Consumers Union Says

Executive Summary

Pfizer's Lipitor and generic lovastatin are rated "best buy" in the statin class of cholesterol lowering drugs by Consumer Reports publisher Consumers Union

You may also be interested in...



Vermont Rx Marketing Price Disclosure Law Exempts “Non-Pill” Products

A recently enacted Vermont law requiring disclosure of the average wholesale price for pharmaceutical products excludes "non-pill" formulations

Vermont Rx Marketing Price Disclosure Law Exempts “Non-Pill” Products

A recently enacted Vermont law requiring disclosure of the average wholesale price for pharmaceutical products excludes "non-pill" formulations

AstraZeneca Crestor Ad Defends Safety, Re-Asserts Superiority Claims

AstraZeneca's full-page ads responding to questions about the safety of Crestor (rosuvastatin) repeat the company's claim that the drug is more effective at lowering cholesterol than other statins

Latest Headlines
See All
UsernamePublicRestriction

Register

PS045099

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel